Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 108

    1.

    Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.

    Podlekareva DN, Mocroft A, Post FA, Riekstina V, Miro JM, Furrer H, Bruyand M, Panteleev AM, Rakhmanova AG, Girardi E, Losso MH, Toibaro JJ, Caylá J, Miller RF, Obel N, Skrahina A, Chentsova N, Lundgren JD, Kirk O; HIV/TB Study Writing Group.

    AIDS. 2009 Nov 27;23(18):2485-95.PMID: 19898216 [PubMed - in process]Related articles

    2.

    Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.

    Kowalska J, Kirk O, Mocroft A, Høj L, Friis-Møller N, Reiss P, Weller I, Lundgren J.

    HIV Med. 2009 Oct 27. [Epub ahead of print]PMID: 19863618 [PubMed - as supplied by publisher]Related articles

    3.

    Let us put biotechnology on the global agenda.

    Bang JK, Kirk O.

    N Biotechnol. 2009 Nov 30;26(5):213-214. Epub 2009 Oct 14. No abstract available. PMID: 19836003 [PubMed - as supplied by publisher]Related articles

    4.

    [Major breakthroughs in the medical treatment]

    Kirk O, Gerstoft J, Lundgren JD, Obel N.

    Ugeskr Laeger. 2009 Mar 2;171(10):787-9. Danish. PMID: 19265601 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

    Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Møller N.

    Circulation. 2009 Feb 17;119(6):805-11. Epub 2009 Feb 2.PMID: 19188509 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

    Reekie J, Mocroft A, Sambatakou H, Machala L, Chiesi A, van Lunzen J, Clumeck N, Kirk O, Gazzard B, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2008 Nov 12;22(17):2381-90.PMID: 18981778 [PubMed - indexed for MEDLINE]Related articles

    7.

    The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.

    Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, Kirk O; EuroSIDA Study Group.

    Cent Eur J Public Health. 2008 Sep;16(3):99-105. Review.PMID: 18935770 [PubMed - indexed for MEDLINE]Related articles

    8.

    Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.

    Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2008 Oct 18;22(16):2187-98.PMID: 18832882 [PubMed - indexed for MEDLINE]Related articles

    9.

    HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

    Monforte A, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

    AIDS. 2008 Oct 18;22(16):2143-53.PMID: 18832878 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Incidence of abacavir hypersensitivity reactions in euroSIDA.

    Bannister WP, Friis-Møller N, Mocroft A, Viard JP, van Lunzen J, Kirk O, Gargalianos P, Bánhegyi D, Chiesi A, Lundgren JD; EuroSIDA Study Group.

    Antivir Ther. 2008;13(5):687-96.PMID: 18771052 [PubMed - indexed for MEDLINE]Related articles

    11.

    Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.

    Podlekareva D, Mocroft A, Kirk O, Reiss P, Aldins P, Katlama C, Kovari H, Stellbrink HJ, D'Arminio Monforte A, Lundgren JD; Eurosida Study Group.

    Scand J Infect Dis. 2008;40(11-12):908-13.PMID: 18609197 [PubMed - indexed for MEDLINE]Related articles

    12.

    Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

    Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

    Clin Infect Dis. 2008 Apr 1;46(7):1101-10.PMID: 18461712 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Loss to follow-up in an international, multicentre observational study.

    Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, Vetter N, Dabis F, Gatell J, Lundgren JD; EuroSIDA study group.

    HIV Med. 2008 May;9(5):261-9.PMID: 18400074 [PubMed - indexed for MEDLINE]Related articles

    14.

    Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

    D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

    Lancet. 2008 Apr 26;371(9622):1417-26. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292. PMID: 18387667 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.

    Bannister WP, Ruiz L, Cozzi-Lepri A, Mocroft A, Kirk O, Staszewski S, Loveday C, Karlsson A, Monforte A, Clotet B, Lundgren JD; EuroSIDA study group.

    AIDS. 2008 Jan 30;22(3):367-76.PMID: 18195563 [PubMed - indexed for MEDLINE]Related articles

    16.

    Unmeasured confounding caused slightly better response to HAART within than outside a randomized controlled trial.

    Hansen AB, Gerstoft J, Kirk O, Mathiesen L, Pedersen C, Nielsen H, Jensen-Fangel S, Sørensen HT, Obel N.

    J Clin Epidemiol. 2008 Jan;61(1):87-94. Epub 2007 Aug 3.PMID: 18083465 [PubMed - indexed for MEDLINE]Related articles

    17.

    Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.

    Mocroft A, Ledergerber B, Zilmer K, Kirk O, Hirschel B, Viard JP, Reiss P, Francioli P, Lazzarin A, Machala L, Phillips AN, Lundgren JD; EuroSIDA study group and the Swiss HIV Cohort Study.

    AIDS. 2007 Sep 12;21(14):1867-75.PMID: 17721094 [PubMed - indexed for MEDLINE]Related articles

    18.

    Chronic renal failure among HIV-1-infected patients.

    Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD.

    AIDS. 2007 May 31;21(9):1119-27.PMID: 17502722 [PubMed - indexed for MEDLINE]Related articles

    19.

    Class of antiretroviral drugs and the risk of myocardial infarction.

    DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD.

    N Engl J Med. 2007 Apr 26;356(17):1723-35.PMID: 17460226 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.

    Holkmann Olsen C, Mocroft A, Kirk O, Vella S, Blaxhult A, Clumeck N, Fisher M, Katlama C, Phillips AN, Lundgren JD; EuroSIDA study group.

    HIV Med. 2007 Mar;8(2):96-104.PMID: 17352766 [PubMed - indexed for MEDLINE]Related articles

    21.

    Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C.

    Mocroft A, Rockstroh J, Soriano V, Kirk O, Viard JP, Caplinskas S, Gasiorowski J, Chiesi A, Phillips AN, Lundgren JD, EuroSIDA Study Group.

    Scand J Infect Dis. 2006;38(11-12):1092-7.PMID: 17148084 [PubMed - indexed for MEDLINE]Related articles

    22.

    Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

    Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD.

    Arch Intern Med. 2006 Aug 14-28;166(15):1632-41.PMID: 16908797 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe.

    Bannister WP, Kirk O, Gatell JM, Knysz B, Viard JP, Mens H, Monforte AD, Phillips AN, Mocroft A, Lundgren JD; EuroSIDA Study Group.

    J Acquir Immune Defic Syndr. 2006 Jun;42(2):229-37.PMID: 16760800 [PubMed - indexed for MEDLINE]Related articles

    24.

    The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

    Law MG, Friis-Møller N, El-Sadr WM, Weber R, Reiss P, D'Arminio Monforte A, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Kirk O, Sabin CA, Phillips AN, Lundgren JD; D:A:D Study Group.

    HIV Med. 2006 May;7(4):218-30.PMID: 16630034 [PubMed - indexed for MEDLINE]Related articles

    25.

    Predictors of hypertension and changes of blood pressure in HIV-infected patients.

    Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, Monforte AD, Morfeldt L, Fontas E, Kirk O, De Wit S, Calvo G, Law MG, Dabis F, Sabin CA, Lundgren JD; Data Collection of Adverse events of anti-HIV Drugs Study Group.

    Antivir Ther. 2005;10(7):811-23. Erratum in: Antivir Ther. 2005;10(8):969. PMID: 16315369 [PubMed - indexed for MEDLINE]Related articles

    26.

    Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

    Mocroft A, Rockstroh J, Soriano V, Ledergerber B, Kirk O, Vinogradova E, Reiss P, Katlama C, Phillips AN, Lundgren JD; EuroSIDA Study Group.

    Antivir Ther. 2005;10(7):779-90.PMID: 16312175 [PubMed - indexed for MEDLINE]Related articles

    27.

    Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.

    Girardi E, Sabin CA, d'Arminio Monforte A, Hogg B, Phillips AN, Gill MJ, Dabis F, Reiss P, Kirk O, Bernasconi E, Grabar S, Justice A, Staszewski S, Fätkenheuer G, Sterne JA; Antiretroviral Therapy Cohort Collaboration.

    Clin Infect Dis. 2005 Dec 15;41(12):1772-82. Epub 2005 Nov 11.PMID: 16288403 [PubMed - indexed for MEDLINE]Related articles

    28.

    Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

    Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, de Wit S, Gatell J, Clotet B, Phillips AN, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2005 Dec 2;19(18):2117-25.PMID: 16284461 [PubMed - indexed for MEDLINE]Related articles

    29.

    Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection.

    Mocroft A, Phillips AN, Soriano V, Rockstroh J, Blaxhult A, Katlama C, Boron-Kaczmarska A, Viksna L, Kirk O, Lundgren JD; EuroSIDA Study Group.

    AIDS Res Hum Retroviruses. 2005 Sep;21(9):743-52.PMID: 16218797 [PubMed - indexed for MEDLINE]Related articles

    30.

    Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

    Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J; EuroSIDA Study Group.

    J Infect Dis. 2005 Sep 15;192(6):992-1002. Epub 2005 Aug 11.PMID: 16107951 [PubMed - indexed for MEDLINE]Related articles

    31.

    Effects of highly active antiretroviral therapy among HIV-infected patients. Results from randomised and observational studies.

    Kirk O.

    Dan Med Bull. 2004 Feb;51(1):63-81. Review. No abstract available. PMID: 16009072 [PubMed - indexed for MEDLINE]Related articles

    32.

    Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection.

    Mocroft A, Phillips AN, Soriano V, Rockstroh J, Blaxhult A, Katlama C, Boron-Kaczmarska A, Viksna L, Kirk O, Lundgren JD; EuroSIDA Study Group.

    AIDS Res Hum Retroviruses. 2005 Jun;21(6):527-36.PMID: 15989457 [PubMed - indexed for MEDLINE]Related articles

    33.

    Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.

    Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD; EuroSIDA Group.

    AIDS. 2005 Mar 24;19(6):593-601.PMID: 15802978 [PubMed - indexed for MEDLINE]Related articles

    34.

    Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.

    Mocroft A, Gatell J, Reiss P, Ledergerber B, Kirk O, Vella S, Blaxhult A, Phillips AN, Lundgren J; EuroSIDA study group.

    AIDS. 2004 Nov 19;18(17):2333-7.PMID: 15577550 [PubMed - indexed for MEDLINE]Related articles

    35.

    Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.

    Mocroft A, Monforte A, Kirk O, Johnson MA, Friis-Moller N, Banhegyi D, Blaxhult A, Mulcahy F, Gatell JM, Lundgren JD; EuroSIDA study group.

    HIV Med. 2004 Nov;5(6):437-47.PMID: 15544697 [PubMed - indexed for MEDLINE]Related articles

    36.

    Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.

    Cabrera C, Cozzi-Lepri A, Phillips AN, Loveday C, Kirk O, Ait-Khaled M, Reiss P, Kjaer J, Ledergerber B, Lundgren JD, Clotet B, Ruiz L; EuroSIDA Study Group.

    Antivir Ther. 2004 Oct;9(5):787-800.PMID: 15535417 [PubMed - indexed for MEDLINE]Related articles

    37.

    Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.

    Røge BT, Barfod TS, Kirk O, Katzenstein TL, Obel N, Nielsen H, Pedersen C, Mathiesen LR, Lundgren JD, Gerstoft J.

    HIV Med. 2004 Sep;5(5):344-51.PMID: 15369509 [PubMed - indexed for MEDLINE]Related articles

    38.

    Cardio- and cerebrovascular events in HIV-infected persons.

    d'Arminio A, Sabin CA, Phillips AN, Reiss P, Weber R, Kirk O, El-Sadr W, De Wit S, Mateu S, Petoumenos K, Dabis F, Pradier C, Morfeldt L, Lundgren JD, Friis-Møller N; Writing Committee of the D:A:D: Study Group.

    AIDS. 2004 Sep 3;18(13):1811-7.PMID: 15316342 [PubMed - indexed for MEDLINE]Related articles

    39.

    Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression.

    Phillips AN, Ledergerber B, Horban A, Reiss P, Chiesi A, Kirk O, Mulchany F, Fisher M, Machala L, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2004 Sep 3;18(13):1795-804.PMID: 15316340 [PubMed - indexed for MEDLINE]Related articles

    40.

    [Decline in AIDS and death rates in the EuroSIDA study. An observational study]

    Kirk O, Mocroft A, Lundgren JD; EuroSIDA-studiet.

    Ugeskr Laeger. 2004 Jun 21;166(26-31):2572-6. Danish. No abstract available. PMID: 15285167 [PubMed - indexed for MEDLINE]Related articles

    41.

    Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.

    Yust I, Fox Z, Burke M, Johnson A, Turner D, Mocroft A, Katlama C, Ledergerber B, Reiss P, Kirk O; EuroSIDA.

    Eur J Clin Microbiol Infect Dis. 2004 Jul;23(7):550-9. Epub 2004 Jun 30.PMID: 15232720 [PubMed - indexed for MEDLINE]Related articles

    42.

    The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.

    Mocroft A, Kirk O, Clumeck N, Gargalianos-Kakolyris P, Trocha H, Chentsova N, Antunes F, Stellbrink HJ, Phillips AN, Lundgren JD.

    Cancer. 2004 Jun 15;100(12):2644-54.PMID: 15197808 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Clinical trial methodology and clinical cohorts: the importance of complete follow-up in trials evaluating the virological efficacy of anti-HIV medicines.

    Kirk O, Lundgren JD.

    Curr Opin Infect Dis. 2004 Feb;17(1):33-7. Review.PMID: 15090887 [PubMed - indexed for MEDLINE]Related articles

    44.

    Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

    Fontas E, van Leth F, Sabin CA, Friis-Møller N, Rickenbach M, d'Arminio Monforte A, Kirk O, Dupon M, Morfeldt L, Mateu S, Petoumenos K, El-Sadr W, de Wit S, Lundgren JD, Pradier C, Reiss P; D:A:D Study Group.

    J Infect Dis. 2004 Mar 15;189(6):1056-74. Epub 2004 Mar 2.PMID: 14999610 [PubMed - indexed for MEDLINE]Related articles

    45.

    Changing incidence of central nervous system diseases in the EuroSIDA cohort.

    d'Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, Justesen US, Vella S, Kirk O, Lundgren J; EuroSIDA Study Group.

    Ann Neurol. 2004 Mar;55(3):320-8.PMID: 14991809 [PubMed - indexed for MEDLINE]Related articles

    46.

    A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.

    Kirk O, Lundgren JD, Pedersen C, Mathiesen LR, Nielsen H, Katzenstein TL, Obel N, Gerstoft J.

    Antivir Ther. 2003 Dec;8(6):595-602.PMID: 14760893 [PubMed - indexed for MEDLINE]Related articles

    47.

    Combination antiretroviral therapy and the risk of myocardial infarction.

    Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group.

    N Engl J Med. 2003 Nov 20;349(21):1993-2003. Erratum in: N Engl J Med. 2004 Feb 26;350(9):955. PMID: 14627784 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

    Gerstoft J, Kirk O, Obel N, Pedersen C, Mathiesen L, Nielsen H, Katzenstein TL, Lundgren JD.

    AIDS. 2003 Sep 26;17(14):2045-52.PMID: 14502007 [PubMed - indexed for MEDLINE]Related articles

    49.

    Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study.

    Florence E, Lundgren J, Dreezen C, Fisher M, Kirk O, Blaxhult A, Panos G, Katlama C, Vella S, Phillips A; EuroSIDA Study Group.

    HIV Med. 2003 Jul;4(3):255-62.PMID: 12859325 [PubMed - indexed for MEDLINE]Related articles

    50.

    Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

    Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, Knysz B, Dietrich M, Phillips AN, Lundgren JD; EuroSIDA study group.

    Lancet. 2003 Jul 5;362(9377):22-9.PMID: 12853195 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...